Akmika 500mg Injection
Marketer
Global Care
Salt Composition
Amikacin (500mg)
Overview Akmika 500mg Injection
Cefuroxime 500mg injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, joint, lung (including pneumonia), brain, and bloodstream infections. Prophylactic use is also common in hospitalized individuals. Its mechanism involves bacterial growth inhibition. Administered intravenously (IV drip) or intramuscularly by a healthcare professional only, self-injection is strictly prohibited. Consistent, evenly-spaced dosing as directed is crucial; incomplete treatment courses risk relapse or intensified infection. Minor injection site reactions and elevated blood urea nitrogen are possible side effects. Persistent symptoms or treatment ineffectiveness warrant medical attention. High doses may rarely cause vertigo, renal impairment, and hearing deficits; regular kidney, hearing, and urine tests may be conducted. Pregnancy contraindicates its use; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Primary Ingredients of Akmika 500mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Akmika 500mg Injection
Infections caused by bacteria
Major Benefits of Akmika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Akmika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Akmika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Akmika 500mg Injection works:
Akmika 500mg Injection is a bacterial growth inhibitor, a type of antibiotic. Its mechanism of action involves disrupting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Akmika 500mg Injection's use alongside alcohol consumption presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
The use of Akmika 500mg Injection is contraindicated during pregnancy due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Akmika 500mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
The administration of Akmika 500mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Akmika 500mg Injection. The prescribed dosage of Akmika 500mg Injection might require modification. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Akmika 500mg Injection in individuals with liver impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Akmika 500mg Injection :
Should you forget to take a dose of Akmika 500mg Injection, seek medical advice.
Facts to Know About Akmika 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently